PlainBillCongress, translated.Legislation. Context. Public interest.Referred to the Subcommittee on Health.
Congressional Research Service
Version 00 · Introduced in House · Jul 25, 2003
Prescription Drug Tampering Prevention Act of 2003 - Amends the Federal Food, Drug, and Cosmetic Act to provide for fines or imprisonment, or both, for an individual for knowingly violating certain provisions by selling or trading adulterated or misbranded prescription drugs. Punishes an individual also for buying or trading for a prescription drug while knowing or having reason to know that the drug was knowingly caused to be adulterated or misbranded. States that in either instance an individual shall be fined in accordance with Federal law relating to crimes and criminal procedure, imprisoned for any term of years or for life, or both.
Modifies provisions pertaining to criminal penalties for committing certain prohibited acts involving food, drugs, devices, or cosmetics. Makes a violation punishable by a fine in accordance with Federal law relating to crimes and criminal procedure, imprisonment for not more than one year, or both. (Current law prescribes a fine of up to $1,000 and/or imprisonment for not more than one year). Makes a second violation, or a violation committed with intent to defraud or mislead, punishable by a fine in accordance with Federal law, imprisonment for not more than three years, or both. (Current law prescribes a fine of up to $10,000 and/or imprisonment for not more than three years.) Makes a violation of provisions pertaining to prescription drug marketing punishable by a fine in accordance with Federal law, imprisonment for not more than ten years, or both. (Current law prescribes a fine of up to $250,000 and/or imprisonment for not more than ten years.)
People & committees
Rep. Deutsch, Peter [D-FL-20] · D–FL
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Referred to the Subcommittee on Health.
Referred to the House Committee on Energy and Commerce.
Introduced in House
Introduced in House
Primary sources
Text links open the official source. We currently store references to these documents.
No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.
Source last updated: Aug 18, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze H.R.2936 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine H.R.2936 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine H.R.2936 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine H.R.2936 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.